Incidence of thrombotic complications in critically ill ICU patients with COVID-19
FA Klok, M Kruip, NJM Van der Meer, MS Arbous… - Thrombosis research, 2020 - Elsevier
Introduction COVID-19 may predispose to both venous and arterial thromboembolism due to
excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation.
Reports on the incidence of thrombotic complications are however not available. Methods
We evaluated the incidence of the composite outcome of symptomatic acute pulmonary
embolism (PE), deep-vein thrombosis, ischemic stroke, myocardial infarction or systemic
arterial embolism in all COVID-19 patients admitted to the ICU of 2 Dutch university hospitals …
excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation.
Reports on the incidence of thrombotic complications are however not available. Methods
We evaluated the incidence of the composite outcome of symptomatic acute pulmonary
embolism (PE), deep-vein thrombosis, ischemic stroke, myocardial infarction or systemic
arterial embolism in all COVID-19 patients admitted to the ICU of 2 Dutch university hospitals …